Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Wix rises after mixed Q4, announces $250M private placement (SeekingAlpha) +++ WIX.COM Aktie +3,21%

GlobeNewswire EN Nachrichten

GlobeNewswire verbreitet Pressemeldungen und Pflichtmitteilungen von börsennotierten Gesellschaften. Der Großteil der Mitteilungen stammt von Unternehmen aus Nordamerika, Großbritannien und den nordeuropäischen Ländern.
 
04.03.26 - 13:06
FERRARI PUBLISHES AGENDA FOR THE 2026 AGM (GlobeNewswire EN)
 
Maranello (Italy), March 4, 2026 - Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari”) announced today that it has published the agenda and the explanatory notes for the 2026 Annual General Meeting of Shareholders (“AGM”), which will be held on April 15, 2026 in Amsterdam, beginning at 9:00 a.m. CEST....
04.03.26 - 13:03
Digital Realty Enters Portugal, Strengthening Southern Europe′s Digital Backbone (GlobeNewswire EN)
 
LONDON, March 04, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world's largest cloud- and carrier-neutral data center platform, today announced its entry into Portugal through the acquisition of a data center facility in Lisbon. This expansion enhances the company's global data center footprint and reinforces its commitment to enabling seamless connectivity across key international markets....
04.03.26 - 13:03
Here to Report Second Fiscal Quarter Financial Results on March 12, 2026 (GlobeNewswire EN)
 
BEIJING, March 04, 2026 (GLOBE NEWSWIRE) -- Here Group Limited (NASDAQ: HERE) (“Here” or the “Company”), an IP-based pop toy company dedicated to creating beloved collectibles and trend-defining experiences, today announced that it plans to release its unaudited financial results for the quarter ended December 31, 2025, before the U.S. market opens on Thursday, March 12, 2026....
04.03.26 - 13:03
Can-Fite′s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study (GlobeNewswire EN)
 
Ramat Gan, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory diseases, today announced results from its Phase IIa open-label study evaluating namodenoson in patients with advanced pancreatic ductal adenocarcinoma (PDAC) who had progressed following prior systemic therapies....
04.03.26 - 13:03
Notice of Annual General Meeting of Shareholders of Kaspi.kz (GlobeNewswire EN)
 
ALMATY, Kazakhstan, March 04, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of JSC Kaspi.kz (Nasdaq: KSPI) hereby announces the Annual General Meeting of Shareholders of JSC Kaspi.kz will be held on 15 April 2026 at 10:00 Astana time at: 154 “А”, Nauryzbai Batyr Street, Almaty, Kazakhstan, 050013....
04.03.26 - 13:03
Climb Announces U.S. Partnership with LogicMonitor (GlobeNewswire EN)
 
EATONTOWN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Climb, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), announced a new partnership with LogicMonitor, the AI-first platform for Autonomous IT....
04.03.26 - 13:03
George Weston Limited Reports Adjusted Diluted Net Earnings Per Common Share Growth of 15.2% in the Fourth Quarter (GlobeNewswire EN)
 
TORONTO, March 04, 2026 (GLOBE NEWSWIRE) -- George Weston Limited (TSX: WN) (“GWL” or the “Company”) today announced its consolidated unaudited results for the 13 weeks ended December 31, 2025(2)....
04.03.26 - 13:03
Boundless Bio to Participate in the Leerink Global Healthcare Conference (GlobeNewswire EN)
 
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Leerink Global Healthcare Conference....
04.03.26 - 13:03
Clairvest Announces New Normal Course Issuer Bid (GlobeNewswire EN)
 
TORONTO, March 04, 2026 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) today announced that the Toronto Stock Exchange has accepted a notice filed by Clairvest of its intention to make a new normal course issuer bid (“NCIB”). Clairvest's current NCIB expires on March 9, 2026. The notice provides that the Corporation may, during the 12-month period commencing March 10, 2026 and ending March 9, 2027, purchase on The Toronto Stock Exchange, or other alternative Canadian trading systems, up to 693,107 common shares in total, being approximately 5% of the outstanding common shares. The average daily trading volume for the six months ending February 27, 2026 was 452 common shares. Daily purchases will be limited to 1,000 common shares, other than block purchase exceptions. Any shares purchased will be cancelled. The price which the Corporation will pay for any such shares will be the market price at the time of acquisition. The actual number of common shares which may be purchased and the timing of ...
04.03.26 - 13:03
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
RESEARCH TRIANGLE PARK, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the compensation committee of BioCryst's board of directors granted six newly-hired employees restricted stock units (RSUs) covering an aggregate of 65,850 shares of BioCryst common stock. The RSUs were granted as of March 2, 2026, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4)....
04.03.26 - 13:03
Dycom Industries, Inc. Reports Fiscal 2026 Fourth Quarter and Annual Results and Provides Fiscal 2027 Outlook (GlobeNewswire EN)
 
Exceeds Top End of Fiscal 2026 Revenue Outlook and Reports Record Q4 ResultsOperational Excellence Drives Record Free Cash FlowCompletes Strategic Acquisition of Power Solutions Accelerating Entry into High-Growth Data Center MarketFiscal 2027 Outlook Reflects Continued Organic Contract Revenue Growth and Adjusted EBITDA Margin Expansion...
04.03.26 - 13:03
EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments (GlobeNewswire EN)
 
        – Both pivotal Phase 3 trials for DURAVYU in wet AMD on track for data readout beginning in mid-2026 –...
04.03.26 - 13:03
Harrow to Present at Leerink Partner′s 2026 Global Healthcare Conference (GlobeNewswire EN)
 
NASHVILLE, Tenn., March 04, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will present at Leerink Partner's 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 8:40 AM ET, in Miami, Florida....
04.03.26 - 13:03
X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference (GlobeNewswire EN)
 
BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that the management team will participate in a fireside chat at the Leerink Global Healthcare Conference on Wednesday, March 11, 2026 at 10:00 a.m. ET in Miami, FL....
04.03.26 - 13:03
FactSet Announces Appointments of Chief AI Officer and Chief Technology Officer to Accelerate Enterprise AI and Platform Strategy (GlobeNewswire EN)
 
NORWALK, Conn., March 04, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ:FDS), a global financial digital platform and enterprise solutions provider, today announced the appointments of Kate Stepp as Chief AI Officer and Bob Stolte as Chief Technology Officer, effective March 2, 2026. These appointments reinforce FactSet's continued focus on harnessing artificial intelligence capabilities to enhance client value across its global technology platform....
04.03.26 - 13:03
Abaxx to Introduce MarketOS™ at FIA Global Cleared Markets Conference to Accelerate Velocity of $915 Billion of Collateral (GlobeNewswire EN)
 
Abaxx to introduce MarketOS™ at the FIA's Global Cleared Markets Conference, March 8–11, to accelerate collateral mobility in cleared markets....
04.03.26 - 13:03
Ligand to Participate in March Investor Conferences (GlobeNewswire EN)
 
Ligand to Participate in March Investor Conferences...
04.03.26 - 13:03
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference (GlobeNewswire EN)
 
BURLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in The Citizens Life Sciences Conference being held March 10-11, 2026 in Miami, FL....
04.03.26 - 13:03
Applied Digital Announces Pricing of $2.15 Billion of Senior Secured Notes to fund Polaris Forge 2 Campus (GlobeNewswire EN)
 
DALLAS, March 04, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (NASDAQ: APLD) (“Applied Digital” or the “Company”), a leading designer, builder and operator of high-performance, sustainably engineered data centers and colocation services for Artificial Intelligence (“AI”), networking, and blockchain workloads, today announced that its subsidiary, APLD ComputeCo 2 LLC (“APLD Compute 2”), has priced a $2.15 billion offering (the “Offering”) of 6.750% senior secured notes due 2031 (the “Notes”) at an issue price of 98%. The Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act. The Offering is expected to close on or around March 10, 2026, subject to market and other conditions....
04.03.26 - 13:03
Rezolute to Participate in the Citizens Life Sciences Conference (GlobeNewswire EN)
 
REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced that management will participate in the Citizens Life Sciences Conference, taking place March 10-11, 2026, in Miami, FL....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer ein blindes Pferd verkaufen will, lobt die Füße. - Bauernregel - Bauernweisheit
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!